SIBN SI-BONE, Inc.
Healthcare$14.67-0.07%ClosedMarket Cap: $650.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.61
P/S
3.16
EV/EBITDA
-85.13
DCF Value
$40.27
FCF Yield
-0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.6%
Operating Margin
-9.7%
Net Margin
-8.1%
ROE
-9.6%
ROA
-6.9%
ROIC
-9.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $52.6M | 79.8% | $-5.1M | $-4.3M | $— | — |
| Q4 null | $56.4M | 79.0% | $-2.5M | $-1.6M | $— | — |
| FY null | $200.9M | 79.6% | $-22.3M | $-18.9M | $— | — |
| Q3 null | $48.7M | 79.8% | $-5.4M | $-4.6M | $— | — |
| Q2 null | $48.6M | 79.8% | $-7.0M | $-6.2M | $— | — |
| Q1 null | $47.3M | 79.7% | $-7.5M | $-6.5M | $— | — |
| Q4 null | $49.0M | 79.1% | $-5.5M | $-4.5M | $— | — |
| FY null | $167.2M | 79.0% | $-35.2M | $-30.9M | $— | — |
| Q3 null | $40.3M | 79.1% | $-7.6M | $-6.6M | $— | — |
| Q2 null | $40.0M | 79.0% | $-10.1M | $-8.9M | $— | — |
| Q1 null | $37.9M | 78.9% | $-12.0M | $-10.9M | $— | — |
| Q4 2023 | $38.9M | 73.8% | $-12.5M | $-11.0M | $-0.27 | — |